It is currently Sun Apr 26, 2015 10:53 pm

News News of Gilenya

Site map of Gilenya » Forum : Gilenya

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Gilenya reduces brain loss in Multiple Sclerosis patients

Image

Pooled data from two large Phase III studies have demonstrated a significant early treatment effect of Novartis' multiple sclerosis pill Gilenya on relapses and MRI outcomes, including brain volume loss.

The data, presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress in Lyons, France, shows that treatment with Gilenya (fingolimod) led to significant benefits on relapse-related outcomes within the first three months and on brain volume loss by six ...
Read more : Gilenya reduces brain loss in Multiple Sclerosis patients | Views : 1532 | Replies : 0




Scottish MS patients finally given access to oral MS drug

Scottish MS patients finally given access to oral MS drug Gilenya®

Image

The Scottish Medicines Consortium (SMC) has today announced that Gilenya® (fingolimod), the world’s first pill for the treatment of highly active relapsing-remitting multiple sclerosis (RRMS), has now been approved for restricted use within NHS Scotland.

Today’s decision means that people with highly active RRMS not responding to treatment with first-line interferon injections now have the option of switching to fingolimod as their next ...
Read more : Scottish MS patients finally given access to oral MS drug | Views : 1486 | Replies : 0


Rethink on MS pill Gilenya gives hope to Scots sufferers

Image

Multiple sclerosis sufferers in Scotland will learn today if the world’s first oral pill to alleviate symptoms of the condition is to be prescribed on the NHS.

The drug, Fingolimod, is already available to MS patients in England and Wales after being approved by the National Institute for Clinical Excellence in March. But the Scottish Medicines Consortium, which evaluates drugs for use in Scotland and ruled earlier this year that it did not provide ...
Read more : Rethink on MS pill Gilenya gives hope to Scots sufferers | Views : 1260 | Replies : 0


Gilyenia and PML

Has anyone got PML from gilyenia. Ive read of a couple of cases but both cases were where the patients took tysabri first so im wondering if anyone developed PML without having taken tysabri ?
Read more : Gilyenia and PML | Views : 1749 | Replies : 0


Rebound and Gilenya

What do you think? Are these high-tech drugs designed to be impossible to stop taking? Do they make the disease worse?
Read more : Rebound and Gilenya | Views : 2005 | Replies : 0


X-Rays and Gilenya?

From my rough understanding, Gilenya has an associated increased risk of cancer. Is there any information regarding it and X-Rays? (apart from avoid)

Thinking about it, flying internationally is a big source of X-Rays.
Read more : X-Rays and Gilenya? | Views : 1722 | Replies : 0


Oral MS drug piloted in North East is available on the NHS

Image

NHS funding for a groundbreaking drug piloted in the North East for patients with multiple sclerosis is now mandatory.

The National Institute for Clinical Excellence (Nice) has stipulated that adults with relapsing remitting MS not responding to treatment with first-line interferon injections should have access to fingolimod, an oral pill that cuts relapses by more than half compared to a standard injection.

Clinical trials that began in 2004 at the regional centre for the ...
Read more : Oral MS drug piloted in North East is available on the NHS | Views : 1358 | Replies : 0


MS drug Gilenya prescriptions slowing

MS drug Gilenya prescriptions slowing due to lack of monitoring facilities

Image


Novartis’ multiple sclerosis (MS) pill Gilenya faces slowing prescriptions in New York because of a lack of facilities to perform first-dose observations, neurologists told Biopharm Insight. However, Novartis has been in contact with a number of clinicians and is working on increasing the number of sites.

A US Food and Drug Administration (FDA) review was initiated after a patient died within 24 hours ...
Read more : MS drug Gilenya prescriptions slowing | Views : 1640 | Replies : 0


Oral MS drug Gilenya slows brain inflammation

Image

The multiple sclerosis medication fingolimod (Gilenya) led to "rapid and sustained" reductions in MRI-documented inflammatory lesion activity, researchers reported.

In a two-year randomized trial, the medication also slowed the rate of brain volume loss compared with placebo, according to Ernst-Wilhelm Radue, MD, of University Hospital Basel in Basel, Switzerland, and colleagues.

Changes in lesion volume over time also favoured the medication rather than placebo, Radue and colleagues reported online in Archives of Neurology.

Combined ...
Read more : Oral MS drug Gilenya slows brain inflammation | Views : 1438 | Replies : 0


 

Login  •  Register


Statistics

Total posts 224956 • Total topics 23551 • Total members 14918


Contact us | Terms of Service